Medical Device News Magazine

Paragonix Launches Comprehensive Digital Platform for Real-Time Tracking of Donor Organs Destined for Transplantation

Technological advancements in donor organ transportation answer the growing demand for comprehensive tracking, monitoring, and data reporting

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Paragonix Technologies, Inc., a leader in Advanced Organ Preservation (AOP) technology, has announced the launch of its new VantagePoint™ Organ Tracking Technology to pioneer a new era of continuous oversight and real-time visibility for donor organs in transit.

Designed to meet the rising standards of transparency and accountability in donor organ transportation, this technology will improve the digital tracking capabilities provided by the Paragonix App, the free-to-download software, paired with all Paragonix Advanced Organ Preservation (AOP) Devices to meet the evolving needs of organ transplant professionals.
Since 2019, the Paragonix App has allowed teams to easily coordinate the logistics of safeguarding a donor organ in transit. In addition to managing HIPAA-compliant team communications, the app actively monitors preservation conditions in real-time and tracks the GPS location of the procurement team en route to the recipient hospital.
“Protecting the gift of life takes a team of skilled professionals to be successful. With teams from different hospitals working together, sometimes on a national level, it is crucial that all involved members can carefully monitor and track the exact location and condition of the valuable organ throughout every step of the process,” said Dr. Lisa Anderson, CEO of Paragonix. “We have always emphasized the importance of delivering transplant professionals the greatest levels of data and visibility, which is why we are proud to continue expanding our custom digital offering with unparalleled levels of tracking insights.”
With the launch of VantagePoint™ Advanced Organ Tracking, Paragonix device users can begin utilizing state-of-the-art GPS technology to capture and transmit accurate location data of the device autonomously, regardless of cellular or Wi-Fi connectivity. The industry’s current standard of care in preservation – carefully placing a donor organ in ice storage – lacks the level of control or data coordination that transplant professionals deserve to access in an era of digital innovation.
The latest Paragonix App update also optimizes the common limitations of air travel, allowing users to directly upload flight information through a new integration of FlightAware® software. This functionality automatically delivers flight tracking data and predictive insights that can determine the plane’s estimated time of arrival, allowing teams to visualize the complete journey to the recipient hospital and act accordingly.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”